These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6791543)

  • 41. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

  • 43. The complex multimeric composition of factor VIII/von Willebrand factor.
    Ruggeri ZM; Zimmerman TS
    Blood; 1981 Jun; 57(6):1140-3. PubMed ID: 6784794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The von Willebrand syndrome.
    Bloom AL
    Semin Hematol; 1980 Oct; 17(4):215-27. PubMed ID: 6160617
    [No Abstract]   [Full Text] [Related]  

  • 45. Nature of von Willebrand factor: a new assay and a specific inhibitor.
    Sarji KE; Stratton RD; Wagner RH; Brinkhous KM
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):2937-41. PubMed ID: 4547258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic problems of von Willebrand's disease in a general hospital laboratory.
    Dahl CJ; McRoyan DK; Liu PI
    Ann Clin Lab Sci; 1983; 13(5):371-8. PubMed ID: 6416137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease.
    McCarroll DR; Ruggeri ZM; Montgomery RR
    J Lab Clin Med; 1984 May; 103(5):704-11. PubMed ID: 6609219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity.
    Montgomery RR; Hathaway WE; Johnson J; Jacobson L; Muntean W
    Blood; 1982 Jul; 60(1):201-7. PubMed ID: 6805535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The rapid differentiation of type IIb von Willebrand's disease from platelet-type (pseudo-) von Willebrand's disease by the "neutral" monoclonal antibody binding assay.
    Scott JP; Montgomery RR
    Am J Clin Pathol; 1991 Dec; 96(6):723-8. PubMed ID: 1746488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ; Sussman II; Hoyer LW
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
    Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW
    Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Von Willebrand's syndrome.
    Mannucci PM
    Recent Results Cancer Res; 1979; 69():125-36. PubMed ID: 382305
    [No Abstract]   [Full Text] [Related]  

  • 54. [Von Willebrand disease--type 2N (case report)].
    Zarnovicanová M; Pelikánová S
    Vnitr Lek; 2003 Apr; 49(4):319-21. PubMed ID: 12793057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Von Willebrand's disease. Clinical picture, diagnosis, and treatment.
    Bowie EJ
    Clin Lab Med; 1984 Jun; 4(2):303-17. PubMed ID: 6209061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Morphological studies of platelet aggregates induced by human von Willebrand factor in platelet-type von Willebrand's disease.
    Takahashi H; Hattori A; Nagayama R; Hanano M; Fuse I; Takizawa S; Takeshige T; Shibata A
    Thromb Res; 1985 May; 38(4):433-8. PubMed ID: 3874446
    [No Abstract]   [Full Text] [Related]  

  • 57. On von Willebrand's disease (vWd).
    Firkin BG; Howard MA
    Br J Haematol; 1976 Feb; 32(2):151-8. PubMed ID: 1082345
    [No Abstract]   [Full Text] [Related]  

  • 58. The spectrum of von Willebrand's disease revisited.
    Bowie EJ; Fass DN; Olson JD; Owen CA
    Mayo Clin Proc; 1976 Jan; 51(1):35-41. PubMed ID: 765637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families.
    Mahasandana C; Suvatte V; Püng-amritt P; Tuchinda S
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):243-7. PubMed ID: 316576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.